Skip to content

dr. Orlent Hans

Maag-, Darm- en Leverziekten
contactgegevens
Maag-, Darm- en Leverziekten

Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C).

SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials. P110-114.dr. Orlent Hans
Maag-, Darm- en Leverziekten

An isolated form of gastrointestinal tuberculosis.

dr. De Wilde Vincentdr. Coenegrachts Kennethdr. Orlent Hansdr. Casselman Jandr. Feryn Tom
01/01/2005
Maag-, Darm- en Leverziekten

Primair scleroserende cholangitis: kenmerken en langdurige opvolging van 123 patiënten.

Tijdschr. voor Geneeskunde 2005, 61, 1177-1185.dr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Discussion on the risk of surgery in patients with cirrhosis.

Acta Gastroenterol Belg 2008;71(1):47.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Chronic infections with the hepatitis B virus in Belgium, cost-effectiveness of antiviral treatment.

KCE Report 127A.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Chronic infections with the hepatitis B virus in Belgium, cost-effectiveness of antiviral treatment.

KCE Report. Part 2. (Orlent: external expert)dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Treatment of Chronic Hepatitis C Genotype 1 with Protease inhibitors: implications for the laboratory of molecular biology.

Noso Info. 2013, XVII (1):13-18.dr. Orlent Hansdr. Reynders Marijke
01/01/2015
Maag-, Darm- en Leverziekten

Wanneer een idiopathisch hypereosinofiel syndroom niet idiopathisch is.

Tijdschr. voor Geneeskunde 2015dr. Vandecasteele Stefaandr. De Wilde Vincentdr. Lodewyck Tomdr. Orlent Hans
01/01/2001
Maag-, Darm- en Leverziekten

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.

Gastroenterology 2001;120:1323-9.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation.

Bone marrow transplantation 2003;32:115-7.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Hepatic osteodystrophy.

Journal of hepatology 2003;38:243.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

[The treatment of hepatitis C].

Nederlands tijdschrift voor geneeskunde 2003;147:1208-13.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Hepatitis C 2002 guidelines: summary and annotations.

Scandinavian journal of gastroenterology Supplement 2003:105-10.dr. Orlent Hans
01/01/2004
Maag-, Darm- en Leverziekten

The treatment of hepatitis C: history, presence and future.

The Netherlands journal of medicine 2004;62:76-82.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.

The New England journal of medicine 2005;353:1630-1; author reply -1.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Digestive diseases and sciences 2005;50:1804-6.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

[Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST].

Nederlands tijdschrift voor geneeskunde 2005;149:2807-9.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

The management of patients with mild hepatitis C.

Acta gastro-enterologica Belgica 2005;68:314-8.dr. Orlent Hans
01/01/2006
Maag-, Darm- en Leverziekten

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38:82-5.dr. Orlent Hans
01/01/2006
Maag-, Darm- en Leverziekten

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

Journal of hepatology 2006;45:539-46.dr. Orlent Hans
01/01/2007
Maag-, Darm- en Leverziekten

Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.

Acta gastro-enterologica Belgica 2007;70:389-420.dr. Orlent Hans
01/01/2007
Maag-, Darm- en Leverziekten

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology 2007;132:15-6, 467-8.dr. Vandecasteele Stefaandr. Selleslag Dominikdr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

Journal of magnetic resonance imaging : JMRI 2008;27:117-24.dr. Rigauts Hansdr. Coenegrachts Kennethdr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

A pilot observational survey of hepatitis C in Belgium.

Acta gastro-enterologica Belgica 2008;71:4-8.dr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Retrieval of a migrated esophagojejunal stent by using the double-balloon enteroscope.

Gastrointestinal endoscopy 2008;67:1198-9.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

European journal of gastroenterology & hepatology 2010;22:1253-9.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.

European journal of gastroenterology & hepatology 2010;22:1443-8.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

European journal of gastroenterology & hepatology 2010;22:494-9.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT.

Results of the Belgian NAFLD registry. Acta gastro-enterologica Belgica 2011;74:9-16.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

Acta gastro-enterologica Belgica 2011;74:317-22.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Transplant international : official journal of the European Society for Organ Transplantation 2011;24:e30-4.dr. Vanhooren Geertdr. Vanopdenbosch Ludodr. Orlent Hansdr. Casselman Jan
01/01/2012
Maag-, Darm- en Leverziekten

HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers.

Acta gastro-enterologica Belgica 2012;75:35-41.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

Journal of hepatology 2012;56:741-2; author reply 2-3.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

Belgian Association for the Study of the L. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta gastro-enterologica Belgica 2012;75:245-59.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

A case of emphysematous gastritis.

Endoscopy 2012;44 Suppl 2 UCTN:E159.dr. De Wilde Vincentdr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Mitochondrial hepatopathy in adults: a case series and review of the literature.

European journal of gastroenterology & hepatology 2013;25:892-8.dr. Orlent Hans
01/01/2013
Overige

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management

European journal of gastroenterology & hepatology 2013;25:613-9.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

One for the road.

European heart journal 2013;34:2500.dr. Debonnaire Philippedr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Abdominal pain and jaundice after colonoscopy.

Endoscopy 2013;45 Suppl 2 UCTN:E131-2.dr. Snauwaert Christophedr. Lievendr. De Wilde Vincentdr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

A suspicious pancreatic mass in chronic pancreatitis: pancreatic actinomycosis.

Case reports in oncological medicine 2015;2015:767365.dr. Lievendr. De Wilde Vincentdr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

High-dose (peg)interferon therapy in treatment-naive, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015;47:87-8.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Prolonged course of hepatic granulomatous disease due to Bartonella henselae infection.

Acta gastro-enterologica Belgica 2016;79:497-9.dr. Vandecasteele Stefaandr. Orlent Hansdr. Reynders Marijke
01/01/2016
Maag-, Darm- en Leverziekten

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

Gastroenterology 2016;150:903-10 e8.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

International journal of molecular sciences 2016;17.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.

Journal of hepatology 2016;65:543-51.dr. Orlent Hans
01/01/2017
Maag-, Darm- en Leverziekten

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.

BMC gastroenterology 2017;17:26.dr. Orlent Hans
01/01/2017
Maag-, Darm- en Leverziekten

Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.

PloS one 2017;12:e0170933.dr. Orlent Hans
01/01/2017
Maag-, Darm- en Leverziekten

Endoscopic submucosal dissection specimens in early colorectal cancer: lateral margins, macroscopic techniques, and possible pitfalls.

Virchows Archiv: an international journal of pathology 2017;470:165-74.dr. Snauwaert Christophedr. Orlent Hans
01/01/2017
Maag-, Darm- en Leverziekten

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.

Clinics and research in hepatology and gastroenterology 2017;41:656-63.dr. Orlent Hans
01/01/2018
Maag-, Darm- en Leverziekten

Disseminated Mycobacterium genavense Infection in an immuno-competent Adult: a case report.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018.dr. Orlent Hans
01/01/2018
Maag-, Darm- en Leverziekten

Eikenella corrodens perirenal abscess resulting from a pancreatic fistula in a patient with chronic pancreatitis.

Acta gastro-enterologica Belgica 2018;81:323-6.dr. Snauwaert Christophedr. De Wilde Vincentdr. Orlent Hans
01/01/2018
Maag-, Darm- en Leverziekten

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.

Alimentary pharmacology & therapeutics 2018;47:1170-80.dr. Orlent Hans
12/01/2018
Laboratoriumgeneeskunde

“Disseminated Mycobacterium genavense Infection in an immuno-competent Adult: a case report.”

Clin Microbiol Infect. 2018 Dec;24(12):1355-1356. doi: 10.1016/j.cmi.2018.07.013. Epub 2018 Jul 21.dr. Orlent Hansdr. Reynders Marijke
Maag-, Darm- en Leverziekten

Prevention of Progression in Chronic Liver Disease- An Update on SNMC (Stronger Neo-Minophagen C).

SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials. P110-114.dr. Orlent Hans
Maag-, Darm- en Leverziekten

An isolated form of gastrointestinal tuberculosis.

dr. De Wilde Vincentdr. Coenegrachts Kennethdr. Orlent Hansdr. Casselman Jandr. Feryn Tom
06/12/2023
Maag-, Darm- en Leverziekten

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study

Journal of Hepatologydr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Radiofrequency Ablation Without Reimbursement: How Good Does It Work?

Gastrointestinal Endoscopy 2016 ; 83 (5): AB451dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

A prospective multicenter Belgian registry of radiofrequency ablation for barrett’s esophagus.

Acta Gastroenterol Belg 2016;79(1): G01.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Versant HCV Genotype 2.0 assay (LiPA) misclassifies the circulating HCV recombinant RF1_2k/1b in genotype 2 patients.

Hepatology, 2016; 64, S1: A821.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Heads or tails: genotyping of Hepatitis C Virus concerning the 2k/1b recombinant.

ECCMID2016.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Versant hcv genotype 2.0 line probe assay (lipa) misclassifies the circulating hcv recombinant rf1_2k/1b in genotype 2 patients .

Acta Gastroenterol Belg 2016;79(1): A36.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in Belgium: comparison with monoinfected patients and impact of hepatitis C virus replication.

Acta Gastroenterol Belg 2016;79(1): A33.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Acta Gastroenterol Belg 2016;79(1): A08.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Light-to-moderate alcohol intake increases the risk of hepatocellular carcinoma in patients with hcv-related compensated cirrhosis: a prospective study.

Acta Gastroenterol Belg 2016;79(1): A01.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

New devices for the bariatric patient.

Minerva chirurgica 2016;71:114-23.dr. Snauwaert Christophedr. Orlent Hansdr. Dillemans Bruno
01/01/2016
Maag-, Darm- en Leverziekten

Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

Gastroenterology 2016;150:903-10 e8.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Pancreatic panniculitis as a paraneoplastic phenomenon of a pancreatic acinar cell carcinoma.

Acta Clin Belg 2016:1-3.dr. De Wilde Vincentdr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.

JIMD reports 2016;25:77-81.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.

J Hepatol 2016;65:543-51.dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Prolonged course of hepatic granulomatous disease due to Bartonella henselae infection.

Acta Gastroenterol Belg 2016; in press.dr. Vandecasteele Stefaandr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Eikenella corrodens perinephric abscess due to pancreatic fistula in chronic pancreatitis.

Case report and literature review. Acta Gastroenterol Belg 2016; accepted.dr. Snauwaert Christophedr. De Wilde Vincentdr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.

dr. Orlent Hans
01/01/2016
Maag-, Darm- en Leverziekten

Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

International journal of molecular sciences 2016;17.dr. Orlent Hans
01/01/2016
Laboratoriumgeneeskunde

“Heads or tails: genotyping of Hepatitis C Virus concerning the 2k/1b circulating recombinant form”.

International Journal of Molecular Sciences (Int J Mol Sci) 2016, 17(9),1384; doi:10.3390/ijms17091384dr. Orlent Hansdr. Reynders Marijke
01/01/2015
Maag-, Darm- en Leverziekten

Sofosbuvir in combination with Simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium.

Hepatology 2015;62, 1 (Suppl): A1091dr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

Efficacy, safety and pharmacokinetics of 12 weeks of simeprevir in combination with tmc647055, ritonavir and jnj-56914845 in genotype 1 hepatitis c virus-infected patients.

APASL 2015.dr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

A high number of advanced adenomas are found in individuals referred from the Flemish colon cancer screening program : a prospective single center quality registry.

Acta Gastroenterologica Belg 2015;78(1): A 105.dr. Lievendr. De Wilde Vincentdr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Acta Gastroenterologica Belg 2015; 78(1): A 29.dr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

suspicious pancreatic mass in chronic pancreatitis: pancreatic actinomycosis.

Case reports in oncological medicine 2015;2015:767365.dr. De Wilde Vincentdr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

High-dose (peg)interferon therapy in treatment-naive, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2015;47:87-8.dr. Orlent Hans
01/01/2015
Maag-, Darm- en Leverziekten

Wanneer een idiopathisch hypereosinofiel syndroom niet idiopathisch is.

Tijdschr. voor Geneeskunde 2015dr. Vandecasteele Stefaandr. De Wilde Vincentdr. Lodewyck Tomdr. Orlent Hans
01/01/2014
Maag-, Darm- en Leverziekten

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Hepatology, Suppl 2014, 60, S1: A141.dr. Orlent Hans
01/01/2014
Maag-, Darm- en Leverziekten

High-dose (peg)interferon therapy in treatmentnaïve, interleukin-28B rs12979860 CT/TT genotype 1 chronic hepatitis C.

Digestive and Liver Disease 2014.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Hépatites virales B et C en Belgique : similitudes et différences épidémiologiques et de prise en charge initiale.

JFHOD 2013. P007259.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Mitochondrial hepatopathy in adults: a case series and review of the literature.

Eur J Gastroenterol Hepatol 2013;25:892-8.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

One for the road.

European heart journal 2013;34:2500.dr. Debonnaire Philippedr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Abdominal pain and jaundice after colonoscopy.

Endoscopy 2013;45 Suppl 2 UCTN:E131-2.dr. Snauwaert Christophedr. De Wilde Vincentdr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

One for the road.

European heart journal 2013;34:2500.dr. Debonnaire Philippedr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Chronic infections with the hepatitis B virus in Belgium, cost-effectiveness of antiviral treatment.

KCE Report 127A.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Treatment of Chronic Hepatitis C Genotype 1 with Protease inhibitors: implications for the laboratory of molecular biology.

Noso Info. 2013, XVII (1):13-18.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Mitochondrial hepatopathy in adults: a case series and review of the literature.

Eur J Gastroenterol Hepatol 2013;25:892-8.dr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report.

Hepatology research : the official journal of the Japan Society of Hepatology 2013;43:991-8.dr. De Wilde Vincentdr. Orlent Hans
01/01/2013
Maag-, Darm- en Leverziekten

Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.

Eur J Gastroenterol Hepatol 2013;25:613-9.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

One for the road

Eur Heart Jdr. Debonnaire Philippedr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers

Acta Gastroenterol Belg 2012;75:35-41.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-742dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-259dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

A case of emphysematous gastritis

44 Suppl 2 UCTN:E159.dr. De Wilde Vincentdr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers.

Acta Gastroenterol Belg 2012;75:35-41.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

IL28B polymorphism and hepatitis C: a genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?

J Hepatol 2012;56:741-2; author reply 2-3.dr. Orlent Hans
01/01/1970
Maag-, Darm- en Leverziekten

Belgian Association for the Study of the L. Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.

Acta Gastroenterol Belg 2012;75:245-59.dr. Orlent Hans
01/01/2012
Maag-, Darm- en Leverziekten

A case of emphysematous gastritis.

Endoscopy 2012;44 Suppl 2 UCTN:E159.dr. De Wilde Vincentdr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

J Hepatol 2011, S: A54.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

Steering Committee of the Belgian Association for the Study of the L. High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT.

Results of the Belgian NAFLD registry. Acta Gastroenterol Belg 2011;74:9-16.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

Belgian Association for the Study of the L. IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?

Acta Gastroenterol Belg 2011;74:317-22.dr. Orlent Hans
01/01/2011
Maag-, Darm- en Leverziekten

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.

Transpl Int 2011;24:e30-4.dr. Vanhooren Geertdr. Vanopdenbosch Ludodr. Orlent Hansdr. Casselman Jan
01/01/2010
Maag-, Darm- en Leverziekten

A Prospective multicenter registry of hepatitis C virus genotype 4 from Belgium.

Hepatology 2010, S: A778.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

J Hepatology; 2010, S276.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

Acta Gastroenterol Belg; 2010;73(1), A97.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients.

Eur J Gastroenterol Hepatol 2010;22:1253-9.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.

Eur J Gastroenterol Hepatol 2010;22:1443-8.dr. Orlent Hans
01/01/2010
Maag-, Darm- en Leverziekten

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B.

Eur J Gastroenterol Hepatol 2010;22:494-9.dr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Discussion on the risk of surgery in patients with cirrhosis.

Acta Gastroenterol Belg 2008;71(1):47.dr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.

J Magn Reson Imaging 2008;27:117-24.dr. Rigauts Hansdr. Coenegrachts Kennethdr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

A pilot observational survey of hepatitis C in Belgium.

Acta Gastroenterol Belg 2008;71:4-8.dr. Orlent Hans
01/01/2008
Maag-, Darm- en Leverziekten

Retrieval of a migrated esophagojejunal stent by using the double-balloon enteroscope.

Gastrointest Endosc 2008;67:1198-9.dr. Orlent Hans
01/01/2007
Maag-, Darm- en Leverziekten

Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement.

Gastroenterology 2007;132:15-6, 467-8.dr. Selleslag Dominikdr. Orlent Hansdr. Vandecasteele Kris
01/01/2007
Maag-, Darm- en Leverziekten

Belgian Association for the Study of the L. Management and treatment of chronic hepatitis B virus

Belgian Association for the Study of the Liver (BASL) 2007 guidelines. Acta Gastroenterol Belg 2007;70:389-420.dr. Orlent Hans
01/01/2006
Maag-, Darm- en Leverziekten

Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool.

Endoscopy 2006;38:82-5.dr. Orlent Hans
01/01/2006
Maag-, Darm- en Leverziekten

Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.

J Hepatol 2006;45:539-46.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Primair scleroserende cholangitis: kenmerken en langdurige opvolging van 123 patiënten.

Tijdschr. voor Geneeskunde 2005, 61, 1177-1185.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.

Dig Dis Sci 2005;50:1804-6.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.

N Engl J Med 2005;353:1630-1; author reply -1.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Isolated increase of the serum aspartate aminotransferase level in a young asymptomatic patient: macro-AST.

Ned Tijdschr Geneeskd 2005;149:2807-9.dr. Orlent Hans
01/01/2005
Maag-, Darm- en Leverziekten

Steering Committee of the Belgian Association for the Study of the L. The management of patients with mild hepatitis C.

Acta Gastroenterol Belg 2005;68:314-8.dr. Orlent Hans
01/01/2004
Maag-, Darm- en Leverziekten

The treatment of hepatitis C: history, presence and future.

Neth J Med 2004;62:76-82.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation.

Bone Marrow Transplant 2003;32:115-7.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Hepatic osteodystrophy.

J Hepatol 2003;38:243.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

The treatment of hepatitis C.

Ned Tijdschr Geneeskd 2003;147:1208-13.dr. Orlent Hans
01/01/2003
Maag-, Darm- en Leverziekten

Hepatitis C 2002 guidelines: summary and annotations.

Scand J Gastroenterol Suppl 2003:105-10.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Cirrose: oorzaken, complicaties en behandeling.

Bruggedr. Orlent Hans
Maag-, Darm- en Leverziekten

Actualites en hepato-gastro-enterologie. Utilité des polymorphismes génétiques dans le traitement de l’hépatite C.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Liver and brain: is there a link?

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis C.

Antwerpendr. Orlent Hans
Maag-, Darm- en Leverziekten

Traitements émergents en hépatogastroentérologie : comment les rendre accessibles à la pratique en Belgique ?

dr. Orlent Hans
Maag-, Darm- en Leverziekten

BASL interuniversity liver course 2007: Moderator.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

“Surgery in patients with cirrhosis” followed by interactive discussion.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

BASL winter meeting 2006.

Bruggedr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis C en extrahepatische manifestaties.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Een kok met acute epigastralgie.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Subobstructie.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Peginterferon and dose-titrated ribavirin for hepatitis C associated nephrotic membranoproliferative glomerulonephritis.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Chronische hepatitis C met normale transaminasen en milde fibrose.

Gentdr. Orlent Hans
Maag-, Darm- en Leverziekten

Endoscopische ballondilataties.

dr. Orlent Hans
Maag-, Darm- en Leverziekten

Bijblijven in hepatologie.

VVGE lentevergadering 2016dr. Orlent Hans
Maag-, Darm- en Leverziekten

Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

Hepatology, Suppl 2014, 60, S1: A141.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Psoriasis: targeted screening for hepatitis.

Oost en West Vlaanderen 2014dr. Orlent Hans
Maag-, Darm- en Leverziekten

1000 Levertransplantaties : een Odyssee voor patiënt en zorgverstrekker.

Gentdr. Orlent Hans
Maag-, Darm- en Leverziekten

Hépatites virales B et C en Belgique : similitudes et différences épidémiologiques et de prise en charge initiale.

JFHOD 2013. P007259.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Radiofrequency in the esophagus: Results of a prospective multicentre Belgian Registry.

Acta Gastroenterol Belg; 2013, D05.dr. Orlent Hans
Maag-, Darm- en Leverziekten

New treatment options for HCV and their influence on diagnostic methods.

4th Scientific meeting Molecular Diagnostics.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Cirrose: oorzaken, complicaties en behandeling.

KHBO Postgraduaat verpleegkunde.dr. Orlent Hans
Maag-, Darm- en Leverziekten

BASL winter meeting 2012 : Moderator.

BASL winter meeting 2012dr. Orlent Hans
Maag-, Darm- en Leverziekten

ACTUALITES EN HEPATO-GASTRO-ENTEROLOGIE. Utilité des polymorphismes génétiques dans le traitement de l’hépatite C.

Societe Royale Belge de Gastroenterologie.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Are newly diagnosed patients with HBV and HCV infection different? Comparison between 2 prospective registries of the Belgian Association for the Study of the Liver .

J Hepatol 2011, S: A54.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Prospective multicenter registry of hepatitis C virus genotype 4 from Belgium.

A Hepatology 2010, S: A778.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis B virus (HBV) infection in Belgium: Results of the Belgian Association for the Study of the Liver (BASL) registry of 1421 HBsAg chronic carriers.

J Hepatology; 2010, S276.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Liver and brain: is there a link?

BASL winter meeting 2010.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis B Virus infection in Belgium: preliminary results of the Belgian association for the study of the liver (BASL) registry of HBsAg chronic carriers.

Hepatology 2009, S: A493.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis B-Delta Virus Co-Infection in Belgium: Preliminary Data of the BASL HDV Registr.

Asian-Pacific Association for the Study of the Liver Meeting 2009, Hong Kong. Hepatology International, 3(1), 200-201, abstract PE470.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies non responders to peginterferon-ribavirin combination therapy after 4 weeks of treatment.

Hepatology, 2008, S: A1236.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis C.

Antwerpendr. Orlent Hans
Maag-, Darm- en Leverziekten

Traitements émergents en hépatogastroentérologie : comment les rendre accessibles à la pratique en Belgique ?

Société Royale Belge de Gastrodr. Orlent Hans
Maag-, Darm- en Leverziekten

BASL interuniversity liver course 2007: Moderator.

BASL interuniversitydr. Orlent Hans
Maag-, Darm- en Leverziekten

Hepatitis C en extrahepatische manifestaties.

Hepatitis C wereld dagdr. Orlent Hans
Maag-, Darm- en Leverziekten

High prevalence of the metabolic syndrome and GGT as a non-invasive marker of advanced fibrosis in a Belgian prospective cohort of NAFLD patients. AASLD Monothematic Conference: Alcoholic and Non-alcoholic Steatohepatitis.

Atlanta, 07-09.09.2006. Poster. Abstract in abstract-book.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Een kok met acute epigastralgie.

VVGE: Het speciale geval.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Chairmen for the lecture on “Surgery in patients with cirrhosis” followed by interactive discussion.

BASL winter meeting 2006dr. Orlent Hans
Maag-, Darm- en Leverziekten

Local Organizer.

BASL winter meeting 2006.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Subobstructie.

VVGE: Het speciale geval.dr. Orlent Hans
Maag-, Darm- en Leverziekten

A pilot observational survey of hepatitis C in Belgium.

Acta Gastroenterologica Belg Suppl2005: A33.dr. Orlent Hans
Maag-, Darm- en Leverziekten

The BASL registry of non alcoholic fatty liver diesase (NAFLD).

Acta Gastroenterologica Belg Suppl2005: A15.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Peginterferon and dose-titrated ribavirin for hepatitis C associated nephrotic membranoproliferative glomerulonephritis.

BASL winter meeting 2004dr. Orlent Hans
Maag-, Darm- en Leverziekten

Chronische hepatitis C met normale transaminasen en milde fibrose.

Gentdr. Orlent Hans
Maag-, Darm- en Leverziekten

Glycyrrhizin given as Stronger Neo-Minophagen C (SNMC) for the treatment of chronic hepatitis C: biochemical and histological effects after 26 weeks of treatment.

Hepatology, 2003, 38, S: A340.dr. Orlent Hans
Maag-, Darm- en Leverziekten

Endoscopische ballondilataties.

AIEVEV symposium 2002dr. Orlent Hans